Witness Must Testify In Medtronic Off-Label Suit: Judge

Law360, New York (February 2, 2012, 12:15 PM EST) -- A Minnesota federal judge on Wednesday upheld a motion compelling a confidential witness to testify in a shareholder class action alleging Medtronic Inc.'s stock price dropped because the medical device company pushed off-label uses for its Infuse spinal graft.

U.S. District Judge Paul A. Magnuson's ruling affirmed a magistrate judge's order for the witness, a former Medtronic employee known as CW2 in the filings, to testify and turn over a document that he tried to withhold by citing Fifth Amendment protection.

Magnuson said the former employee's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.